• Image for Novartis to acquire Avidity Biosciences for about $12 billion
Images can be generated using AI

Novartis to acquire Avidity Biosciences for about $12 billion

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company...

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatment… [+1398 chars]

What to Read Next
More on
Cardiology